Waverley Pharma's market cap is currently C$1.08M. The company's EPS TTM is C$0; its P/E ratio is ―; Waverley Pharma is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
